biblio

Found 5 results
Filters: Keyword is chemotherapy  [Clear All Filters]
2017
S. Iram, “Gold nanoconjugates reinforce the potency of conjugated cisplatin and doxorubicin”, Colloids and Surfaces B: Biointerfaces, vol. 160, pp. 254-264, 2017.
2016
A. Kulkarni, Rao, P., Natarajan, S., Goldman, A., Sabbisetti, V. S., Khater, Y., Korimerla, N., Chandrasekar, V., Mashelkar, R. Anant, and Sengupta, S., “Reporter nanoparticle that monitors its anticancer efficacy in real time”, Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 15, pp. E2104-E2113, 2016.
2012
P. Sengupta, Basu, S., Soni, S., Pandey, A., Roy, B., Oh, M. S., Chin, K. T., Paraskar, A. S., Sarangi, S., Connor, Y., Sabbisetti, V. S., Kopparam, J., Kulkarni, A., Muto, K., Amarasiriwardena, C., Jayawardene, I., Lupoli, N., Dinulescu, D. M., Bonventre, J. V., Mashelkar, R. Anant, and Sengupta, S., “Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity”, Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 28, pp. 11294-11299, 2012.
2010
A. S. Paraskar, Soni, S., Chin, K. T., Chaudhuri, P., Muto, K. W., Berkowitz, J., Handlogten, M. W., Alves, N. J., Bilgicer, B., Dinulescu, D. M., Mashelkar, R. Anant, and Sengupta, S., “Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy”, Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 28, pp. 12435-12440, 2010.
2009
P. Chaudhuri, Paraskar, A., Soni, S., Mashelkar, R. Anant, and Sengupta, S., “Fullerenol-cytotoxic conjugates for cancer chemotherapy”, ACS Nano, vol. 3, no. 9, pp. 2505-2514, 2009.